-       Report 
- October 2025
-  188 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  279 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          From       €3131EUR$3,500USD£2,754GBP 
              The Implantable Cardiac Rhythm Management Device (CRM) market is a subset of the larger Cardiovascular Devices market. CRM devices are used to monitor and treat cardiac arrhythmias, or abnormal heart rhythms. These devices are implanted in the body and can detect and treat arrhythmias, as well as provide data to physicians for diagnosis and treatment. CRM devices include pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.
CRM devices are    used to treat a variety of cardiac conditions, including bradycardia, tachycardia, and atrial fibrillation. They are also used to monitor heart rate and rhythm, and to provide data to physicians for diagnosis and treatment.
Some of the major companies in the Implantable Cardiac Rhythm Management Device market include Medtronic, Abbott, Boston Scientific, Biotronik, and Sorin Group. Show Less   Read more